FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Olympia Compounding Pharmacy dba Olympia Pharmacy Formula F2 Recall

Formula F2, Papaverine 9 mg/mL

Olympia Compounding Pharmacy dba Olympia Pharmacy · Orlando, FL

Risk level
Class II
Reported by FDA
May 4, 2022
Recall ID
D-0821-2022
Check your lot numberHow we source this data

Summary

Olympia Compounding Pharmacy dba Olympia Pharmacy recalled Formula F2 starting Apr 4, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0821-2022 on May 4, 2022. Reason: CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated. Status: Terminated.

Why it was recalled

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Product description

Formula F2, Papaverine 9 mg/mL . Phentolamine 1 mg/mL . Alprostadil 10 mcg/mL . Atropine 0.1 mg/mL, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0002-10.

Lot numbers, UPCs & expiration codes

Lots: G48C20 BUD: 7/20/2022, G48B20 BUD: 7/22/2022

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0821-2022
Classification
Class II
Status
Terminated
Recall initiated
Apr 4, 2022
FDA report date
May 4, 2022
Quantity
257 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy

Original FDA data

Every field from FDA enforcement report D-0821-2022, exactly as published.

Show all FDA fields
City
Orlando
State
FL
Status
Terminated
Country
United States
Event ID
89938
Address
6700 Conroy Rd Ste 155
Code information
Lots: G48C20 BUD: 7/20/2022, G48B20 BUD: 7/22/2022
Postal code
32835-3515
Report date
May 4, 2022
Product type
Drugs
Recall number
D-0821-2022
Classification
Class II
Recalling firm
Olympia Compounding Pharmacy dba Olympia Pharmacy
Product quantity
257 vials
Termination date
Jun 17, 2024
Reason for recall
CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated
Voluntary / mandated
Voluntary: Firm initiated
Product description
Formula F2, Papaverine 9 mg/mL . Phentolamine 1 mg/mL . Alprostadil 10 mcg/mL . Atropine 0.1 mg/mL, 10 mL Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0002-10.
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Apr 4, 2022
Initial firm notification
Letter
Center classification date
Apr 27, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0821-2022, published May 4, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls